Senate Hearing: US Officials Criticized for Inadequate E-Cigarette Regulation, Including ELFBAR

Regulations by 2FIRSTS.ai
Jun.13.2024
Senate Hearing: US Officials Criticized for Inadequate E-Cigarette Regulation, Including ELFBAR
US Senators criticize health officials for failing to tackle illegal e-cigarette issue, calling for stricter enforcement in hearing.

According to a report from the Associated Press on June 12th, during a hearing held by the Senate Judiciary Committee in the United States on Wednesday, senators harshly criticized senior officials from the health and law enforcement departments for their failure to effectively combat the problem of illegal e-cigarettes in the United States, in an effort to combat the epidemic of youth e-cigarette use.

Senate Hearing: US Officials Criticized for Inadequate E-Cigarette Regulation, Including ELFBAR
Chairman of the Senate Judiciary Committee and Illinois Democrat Dick Durbin. | Source: Associated Press

 

The hearing will be chaired by Senator Dick Durbin, who has long been opposed to e-cigarette products. During the hearing, Democratic and Republican members of the Senate Judiciary Committee expressed their frustration and anger at officials from the Food and Drug Administration (FDA) and the Department of Justice for their efforts to regulate the vaping industry.

Senate Hearing: US Officials Criticized for Inadequate E-Cigarette Regulation, Including ELFBAR
Translation: FDA Center for Tobacco Products Director Brian King | Image Source: Associated Press

 

Among them, e-cigarette brands like ELFBAR have become the most popular choice among American youth who use e-cigarettes.

Senate Hearing: US Officials Criticized for Inadequate E-Cigarette Regulation, Including ELFBAR
Republican Senator Thom Tillis | Image source: Associated Press

 

Senate Judiciary Committee Chairman and Illinois Democrat Dick Durbin stated,

Senate Hearing: US Officials Criticized for Inadequate E-Cigarette Regulation, Including ELFBAR
Texas Senator John Cornyn | Image source: Associated Press

 

I just don't understand how the FDA and Justice Department allow thousands of products to remain on store shelves, even when manufacturers have not obtained authorization and in some cases have not even submitted applications.

Senate Hearing: US Officials Criticized for Inadequate E-Cigarette Regulation, Including ELFBAR

 

He referenced a photo of a colorful inventory of e-cigarettes, including Dragon Fruit and Watermelon Bubblegum flavors, sold at a store near the FDA headquarters in Silver Spring, Maryland.

 

These illegal products, based on their taste, are clearly designed for children, yet are being sold under the shadow of the FDA building. How can such a thing be allowed to happen?

 

You have completely failed to fulfill your responsibilities.

 

Deputy Bureau Chief Brian King of the FDA Tobacco Products Center told DeBine.

 

Brian King defended this by stating that the FDA has issued warning letters and civil fines to manufacturers and retailers, and has collaborated with other agencies such as consumers and border protection to seize illegal products. In addition, the approval process has slowed down as a result of a backlog of applications for approval submitted by e-cigarette companies, and regulatory agencies have a legal obligation to review these applications.

 

Due to the large quantity of the product, we must take time to conduct a scientific and legal review of 27 million applications.

 

The FDA has approved a few e-cigarettes as alternatives for adult smokers. All other products on the market, including major sellers like Juul, are awaiting review or are considered illegal by regulatory agencies. A industry lobbyist told the committee that the FDA has rejected over 99% of companies' applications, leading to an unsustainable market situation.

 

The FDA and Department of Justice have banned approximately six e-cigarette companies from selling products that appeal to minors, but more manufacturers continue to release new products, particularly disposable e-cigarettes.

 

Assistant Attorney General Arun Rao informed the Senator that regulators at the Department of Justice and other agencies have deemed the issue of e-cigarettes a "top priority" across the entire administration. In response, Senator Durbin stated, "I don't want empty words, I want action.

 

On Monday (10th), the FDA and the Department of Justice announced the establishment of a new task force to combat illegal e-cigarette sales.

 

Republican Senator Thom Tillis referred to the timing of the notice as a "political stunt" and criticized other federal agencies for not participating in the initiative, including Customs and Border Protection.

 

If the time it takes to establish a special working group is not enough to show how seriously FDA is about cracking down on the proliferation of illegal e-cigarettes, then excluding the U.S. Customs and Border Protection from the special working group will further illustrate this point.

 

He urged officials to focus law enforcement efforts on Chinese brands rather than large American manufacturers like Reynolds Tobacco.

 

According to retail sales data analyzed by Goldman Sachs, the two top-selling disposable products - Breeze and ELFBAR, had sales exceeding $500 million last year. Despite both brands being regulated by the FDA, they continue to be widely sold in the market, with some brands even rebranding with new names, logos, and flavors. Last year, over half of the 2.8 million American youth and young adults who use e-cigarettes reported using ELFBAR.

 

Brian Kim pointed out that products like ELFBAR cannot be legally sold in China, as the Chinese government has already banned non-tobacco flavored e-cigarettes.

 

In response, Texas Senator John Cornyn has vowed to introduce legislation to address what he describes as an "outrageous and unacceptable situation.

 

Click on the text or image to read: ELFBAR's new product AF5000 accused of circumventing UK e-cigarette regulations, EU issues "danger warning" to member states.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives
Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Pennsylvania began enforcing its electronic nicotine delivery system directory restrictions on October 19, 2026. Among 163 product listings recorded before enforcement, four CrossBar 20K disposables stood out with 13mL capacity, advertised puff counts of up to 20,000 and a flattened design distinct from conventional pod systems and compact disposables. Historical records identify earlier 1.3mL CrossBar products associated with Romo LLC, while newer 13mL products appeared in several state directories beginning in 2025 under entities including Blue Nine LLC. PMTA compliance expert Mr. K identified amendments and application ownership transfers as possible regulatory mechanisms, although neither has been confirmed in this case. Separately, Reynolds' $7.5 million acquisition of 16 PACHA products and related assets illustrates the commercial value of products linked to historic PMTA submissions.
Special Report
Oct.22
UK ONS Data: Vaping Rate Among Women Aged 25–34 Reaches 18.3%, Compared With 14.4% for Men
UK ONS Data: Vaping Rate Among Women Aged 25–34 Reaches 18.3%, Compared With 14.4% for Men
The vaping rate among women aged 25 to 34 in Great Britain reached 18.3% in 2025, up from 13.7% in 2024 and 8.3% in 2020, according to data from the Office for National Statistics (ONS). The figure was the highest for this group since records began in 2014 and exceeded the 14.4% recorded among men of the same age. Adults aged 25 to 34 also overtook those aged 16 to 24 as the age group with the highest vaping prevalence. Overall, about 5.4 million adults in Great Britain used e-cigarettes in 2025, broadly unchanged from the previous year.
DATA
Oct.13
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
The U.S. Food and Drug Administration has revised the rules under Import Alert 98-07 to incorporate its May 2026 enforcement-priority policy for certain electronic nicotine delivery systems marketed without premarket authorization. The alert continues to allow detention without physical examination, or DWPE, for ENDS lacking required marketing authorization, while directing field divisions to apply the May risk-based framework. When necessary, detention or refusal decisions must also undergo review by the FDA's Center for Tobacco Products. Products including PACHA and Vuse Pro have already emerged as industry examples of the May policy, although enforcement discretion does not constitute FDA marketing authorization.
News
Sep.28 by 2Firsts Perspectives
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07